Our current observation that anti-TNFα and anti-IL-1 therapies had no effect on increased circulating IL-17 levels in rat AIA supports the hypothesis that IL-17 acts upstream of IL-1 and TNF in experimental arthritis [59,60]. Here, IL1B is linked to arthritic joint disease.